Search Results - "Splawski, Judy"

NASPGHAN Clinical Report on Postoperative Recurrence in Pediatric Crohn Disease by Splawski, Judy B., Pffefferkorn, Marian D., Schaefer, Marc E., Day, Andrew S., Soldes, Oliver S., Ponsky, Todd A., Stein, Philip, Kaplan, Jess L., Saeed, Shehzad A.

“…ABSTRACT Pediatric Crohn disease is characterized by clinical and endoscopic relapses. The inflammatory process is considered to be progressive and may lead to…”
Get full text

NASPGHAN Clinical Report on the Evaluation and Treatment of Pediatric Patients With Internal Penetrating Crohn Disease: Intraabdominal Abscess With and Without Fistula by Pfefferkorn, Marian D., Marshalleck, Francis E., Saeed, Shehzad A., Splawski, Judy B., Linden, Bradley C., Weston, Benjamin F.

Get full text

Challenges in pediatric inflammatory bowel disease by Bousvaros, Athos, Sylvester, Francisco, Kugathasan, Subra, Szigethy, Eva, Fiocchi, Claudio, Colletti, Richard, Otley, Anthony, Amre, Devendra, Ferry, George, Czinn, Steven J., Splawski, Judy B., Oliva‐Hemker, Maria, Hyams, Jeffrey S., Faubion, William A., Kirschner, Barbara S., Dubinsky, Marla C.

“…It is estimated that of the >1 million individuals in the United States with inflammatory bowel disease (IBD), ≈︁100,000 are children. IBD that begins in…”
Get full text

Reversal of Immunogenicity in Pediatric Inflammatory Bowel Disease Patients Receiving Anti-Tumor Necrosis Factor Medications by Kang, Elise, Khalili, Ali, Splawski, Judy, Sferra, Thomas J, Moses, Jonathan

“…Loss of response to anti-tumor necrosis factor (anti-TNF) agents in the treatment of inflammatory bowel disease (IBD) is a major consideration to maintain…”
Get full text

S1083 Is Thymic Stromal Lymphopoietin (TSLP) a Key Player in Eosinophilic Esophagitis (EE): A Pilot Study by Gorla, Kiranmai, Splawski, Judy B, Dawson, Dawn

Get full text

Reversal of Immunogenicity in Pediatric Inflammatory Bowel Disease Patients Receiving Anti-Tumor Necrosis Factor Medications by Kang, Elise, Khalili, Ali, Splawski, Judy, Sferra, Thomas J, Moses, Jonathan

“…Loss of response to anti-tumor necrosis factor (anti-TNF) agents in the treatment of inflammatory bowel disease (IBD) is a major consideration to maintain…”
Get full text

Helicobacter pylori and Nonulcer Dyspepsia: Is There a Relation? by Splawski, Judy B.

Get full text

Inflammatory disease in HLA-B27 transgenic rats by Taugor, Joel D., Maika, Shanna D., Satumtira, Nimman, Dorris, Martha L., McLean, Ian Lochlan, Yanagisawa, Hiromi, Sayad, Alain, Stagg, Andrew J., Fox, Graham M., Le O'Brein, Anne, Rehman, Muhammad, Zhou, Ming, Weiner, Allison L., Splawski, Judy B., Richardson, James A., Hammer, Robert E.

“…A spontaneous inflammatory disease in rats transgenic for HLAB27 resembles the B27‐associated human spondyloarthropathies, Colitis and arthritis, the two most…”
Get full text

Differences in Clinical Presentation of Eosinophilic Esophagitis in Pediatric Patients with Ulcerative Colitis and Crohn's Disease by Splawski, Judy, Aktay, Atiye, Perry, Sharon, Baez-Socorro, Virginia, Delozier, Sarah, Sferra, Thomas, Moses, Jonathan

“…Eosinophilic Esophagitis (EoE) is an inflammatory condition characterized by T helper-2 (Th2) cytokines. Ulcerative colitis (UC) and Crohn's Disease (CD) are…”
Get full text

Differences in Clinical Presentation of Eosinophilic Esophagitis in Pediatric Patients With Ulcerative Colitis and Crohn Disease by Splawski, Judy, Aktay, Atiye Nur, Perry, Sharon, Baez‐Socorro, Virginia, DeLozier, Sarah, Sferra, Thomas J., Moses, Jonathan

“…Significance: Eosinophilic esophagitis (EoE) is an inflammatory condition characterized by T helper‐2 (TH2) cytokines. Ulcerative colitis (UC) and Crohn…”
Get full text

Mo1910 SAFETY AND EFFICACY OF SUPRATHERAPEUTIC SERUM INFLIXIMAB LEVELS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE by Swamy, Supraja S., Nasab, Arian, Malay, Sindhoosha, Perry, Sharon, Splawski, Judy B., Finkler, Michael D., Moses, Jonathan

Get full text

P139 CORRELATION OF CLINICAL REMISSION WITH MUCOSAL HEALING IN PEDIATRIC INFLAMMATORY BOWEL DISEASE by Young, Denise, Mehta, Megha, Minich, Nori, Splawski, Judy, Sferra, Thomas J., Moses, Jonathan

Get full text

Time to antibody detection and associated factors for presence of anti-drug antibodies in pediatric inflammatory bowel disease patients treated with anti-TNF therapy by Moses, Jonathan, Lambert-Jenkins, Kristin, Momotaz, Hasina, Sattar, Abdus, Debanne, Sara M, Splawski, Judy, Sferra, Thomas J

“…BACKGROUND:Loss of response in pediatric inflammatory bowel disease patients treated with biologic medications can be due to development of anti-drug…”
Get full text

P139 CORRELATION OF CLINICAL REMISSION WITH MUCOSAL HEALING IN PEDIATRIC INFLAMMATORY BOWEL DISEASE by Young, Denise, Mehta, Megha, Minich, Nori, Splawski, Judy, Sferra, Thomas J, Moses, Jonathan

“…Abstract Background IBD therapeutic endpoints have evolved over time with the addition of mucosal healing (MH) as a treatment goal. Adult data suggest patients…”
Get full text

Rates of Mucosal Healing and Correlation to Clinical Assessment in Pediatric Crohnʼs Disease: 1045 by Do, Denise, Mehta, Megha, Perry, Sharon, Splawski, Judy, Sferra, Thomas J., Moses, Jonathan

Get full text

Comparison of Short-Term Outcomes for Standard Versus Nonstandard Induction Dosing of Infliximab for Pediatric Inflammatory Bowel Disease by Nasab, Arian S., Finkler, Michael, DeLozier, Sarah, Sferra, Thomas J., Splawski, Judy, Moses, Jonathan

“…OBJECTIVERecent studies have emphasized the early use of infliximab (IFX) in pediatric patients with inflammatory bowel disease. Standard dosing of 5…”
Get full text

Superior Mesenteric Artery Syndrome Complicated by Gastric Mucosal Necrosis Following Congenital Scoliosis Surgery: A Case Report by Moyer, Kathleen, Thompson, George H., Poe-Kochert, Constance, Splawski, Judy

“…This is a report of severe superior mesenteric artery (SMA) syndrome in an 11-year-old girl with congenital scoliosis following posterior spinal fusion and…”
Get full text

Association of Fecal Calprotectin With Endoscopic and Histologic Activity in Pediatric Inflammatory Bowel Disease by Crawford, Erin, Gestrich, Catherine, Malay, Sindhoosha, Young, Denise, Perry, Sharon, Splawski, Judy, Sferra, Thomas J, Saab, Shahrazad, Moses, Jonathan

“…Fecal calprotectin (FC) is a noninvasive marker of intestinal inflammation used for screening and ongoing monitoring of inflammatory bowel disease (IBD); it is…”
Get full text

NASPGHAN Clinical Report on the Evaluation and Treatment of Pediatric Patients With Internal Penetrating Crohn Disease by Pfefferkorn, Marian D., Marshalleck, Francis E., Saeed, Shehzad A., Splawski, Judy B., Linden, Bradley C., Weston, Benjamin F.

Get full text

Transmission of Donor Melanoma after OLT in a Teenager with Urea Cycle Defect – A Case Report: 908 by Bauman, Lara, Splawski, Judy, Redline, Ray, Blanchard, Samra S.

Get full text